Orchard Hill Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opko Health
OPK
|
+$4.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$8.59M |
| 2 |
GM.WS.B
General Motors Company
GM.WS.B
|
+$5.8M |
| 3 |
BZT
BEAZER HOMES USA, INC. TANGIBLE EQUITY UNIT
BZT
|
+$2.23M |
| 4 |
Lam Research
LRCX
|
+$463K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.41% |
| 2 | Technology | 0% |
Similar funds
Orchard Hill Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Orchard Hill Capital Management held 23 positions worth $2.17B, up 11% from $1.95B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Orchard Hill Capital Management withdrew a net $1.8B in Q1 2014, closing 4 positions and reducing 3 holdings. Its most notable exit was General Motors Company, an estimated $5.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0.41% of assets, down from 0.56% a quarter earlier, followed by Technology.
Against the trend, Orchard Hill Capital Management opened a new position in Opko Health worth $4.3M.
- Orchard Hill Capital Management's largest Q1 2014 buy was Opko Health: 461,000 shares worth $4.3M.
- Orchard Hill Capital Management's biggest Q1 2014 reduction was Supernus Pharmaceuticals, cutting an estimated $8.59M.
- Orchard Hill Capital Management fully exited General Motors Company in Q1 2014, selling an estimated $5.8M.
- Orchard Hill Capital Management's ten largest holdings make up 96% of its $2.17B portfolio in Q1 2014.
- Orchard Hill Capital Management opened 2 new positions and closed 4 in Q1 2014.
- Orchard Hill Capital Management's portfolio value rose 11% quarter-over-quarter to $2.17B.
Based on Orchard Hill Capital Management's 13F filing for Q1 2014, filed 15 May 2014.